ACIU
AC Immune S.A.
ACIU's outlook is improving, though it still trails on the overall score.
UNH
UnitedHealth Group Incorporated
UNH has the edge over ACIU overall, supported by stronger fundamentals and lower modeled downside.
ACIU Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| Under pressure | |
| Strong |
ACIU's balance sheet is currently strong, but its revenue, profitability and cash flow are under pressure.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
ACIU PE Valuation
ACIU has no meaningful PE right now: it lost money over the past year.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
ACIU Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Strong growth | |
| -- | |
| Limited | |
| High |
Analysts expect ACIU to return to profit, with revenue growing.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
ACIU Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.52 | +$0.08 |
| Q1 2026 | -$0.79 | -$0.16 |
| Q4 2025 | -$0.84 | -$0.23 |
| Q3 2025 | -$0.85 | -$0.35 |
| Q2 2025 | -$0.60 | +$0.18 |
| Q1 2025 | -$0.63 | +$0.11 |
| Q4 2024 | -$0.61 | +$0.17 |
| Q3 2024 | -$0.50 | +$0.48 |
ACIU is still losing money, but far less than before: $0.52 per share over the past year, against $1.23 at its worst in mid-2021.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH has the edge over ACIU on earnings quality, reporting a profit while its opponent remains loss making.
ACIU Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $18.2M | +1057% |
| Q1 2026 | $1.3M | +13% |
| Q4 2025 | $406.9K | -70% |
| Q3 2025 | $1.1M | -96% |
| Q2 2025 | $1.6M | +90% |
| Q4 2024 | $1.4M | -92% |
| Q4 2023 | $17.8M | +1479813% |
| Q4 2020 | $1.1M | +9.8% |
ACIU's revenue is recovering but still below its 2019 peak: $18M last quarter, up 1057% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 7.9% | +1492 points |
| Q1 2026 | -1322% | +635 points |
| Q4 2025 | -4262% | -2625 points |
| Q3 2025 | -1722% | -1750 points |
| Q2 2025 | -1485% | +1567 points |
| Q1 2025 | -1957% | N/A |
| Q4 2024 | -1637% | -1614 points |
| Q3 2024 | 29% | N/A |
ACIU has the edge over UNH on profitability, with a higher operating margin.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH has the edge over ACIU on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH's operating margin was 5.8% last quarter, up 2 points from the same quarter a year ago.
ACIU Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $0 | +$19.2M |
| Q1 2026 | $0 | +$23.1M |
| Q4 2025 | -$19.9M | -383% |
| Q3 2025 | -$22.1M | -$4.9M |
| Q2 2025 | -$19.2M | -122% |
| Q1 2025 | -$23.1M | -2575% |
| Q4 2024 | $7M | +$26.7M |
| Q3 2024 | -$17.2M | -$881.2K |
ACIU has burned cash in most quarters: −$42M over the past year, against −$53M the year before.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over ACIU on cash generation, producing positive trailing cash flow while its opponent burns cash.
ACIU Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | -1.9% | -2M shares |
| 3 years | +17% | +14.5M shares |
| 5 years | +34% | +25M shares |
| Available history | +37% | +26.4M shares |
ACIU has the edge over UNH on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | $6,019 |
| Q4 2024 | — |
| Q3 2024 | — |
ACIU hasn't bought back shares in the past year.
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has 902M diluted shares, down 0.7% from a year ago, with $5B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
ACIU Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2019 | -4.3x | Net Cash |
| Q3 2019 | -4.3x | Net Cash |
ACIU has more cash than debt.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
ACIU Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.0 | Neutral |
| Stochastic | 18.0 | Oversold |
ACIU's weekly RSI is 40 (neutral) and its Stochastic is 18 (oversold).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
ACIU PE vs Healthcare Sector
| Metric | ACIU | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
ACIU has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
ACIU Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.39 | 10% below |
| 20 week MA | $2.47 | 13% below |
| 50 week MA | $2.74 | 22% below |
| 100 week MA | $2.57 | 17% below |
| 200 week MA | $2.81 | 24% below |
ACIU is in a downtrend: it's below all five of its weekly moving averages, and 24% below its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over ACIU on trend strength, trading above more of its moving averages.
ACIU Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $8.39 | $5.51 | -34% |
| 2021 | $5.51 | $5.39 | -2.2% |
| 2022 | $5.39 | $1.75 | -68% |
| 2023 | $1.75 | $5.00 | +186% |
| 2024 | $5.00 | $2.73 | -45% |
| 2025 | $2.73 | $3.13 | +15% |
| 2026 YTD | $3.13 | $2.14 | -32% |
ACIU's yearly returns have swung widely, from +186% in 2023 to −68% in 2022. It's down 32% so far in 2026.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over ACIU on returns for 2026, with the stronger performance.